Annual Research Survey Results

Which research areas/ topics should be the priorities of SPD and PeDRA for the next 3 years? Please select your top 10 priorities.

PRIORITY RESPONSE PERCENT
Inflammatory disorders- Atopic Dermatitis 63%
Vascular anomalies- Vascular malformations 61%
Vascular anomalies- Hemangiomas and vascular tumors 55%
Hair and nail disease- Alopecia Areata 44%
Inflammatory disorders- Psoriasis 44%
Lasers and surgery applications, effectiveness and outcomes 41%
Genetic Skin Disease- Epidermolysis Bullosa 40%
Vitiligo 40%
Genetic Skin Disease- Mosaicism 39%
Education 38%
Neonatal dermatology, including premature skin 38%
Collagen vascular and rheumatologic disorders 35%
Genetic Skin Disease- Disorders of Cornification 31%
Cutaneous malignancy 29%
Melanocytic nevi (congenital and acquired) 29%
Genetic Skin Disease- Neurocutaneous disorders (Neurofibromatosis, Tuberous Sclerosis) 26%
Teledermatology 26%
Inflammatory disorders- Autoinflammatory syndromes 24%
Inflammatory disorders- Acne 23%
Infectious skin disease- Molluscum contagiosum and warts 21%
Genetic Skin Disease- Tumor syndromes 18%
Inflammatory disorders- Contact Dermatitis 18%
Immunobullous disorders 16%
Genital dermatoses 11%
Hyperhidrosis 11%
Mucocutaneous reactions to cancer therapies 10%
Pigmentary disorders- not vitiligo 10%
Hair and nail disease- other, not alopecia areata 9%
Benign cutaneous tumors (other than nevi) 6%
Genetic Skin Disease- Ectodermal Dysplasias 6%
Dermatopathology 5%
Genetic Skin Disease- Other (Specify Below) 5%
Infectious skin disease- other, not molluscum contagiosum and warts 4%


Which types of studies should be priorities of SPD and PeDRA for the next 3 years? Rank 3 choices.

Priority Highest Priority Ranked 1 Ranked 2 Lowest Priority Ranked 3
Clinical trials (Phase I-IV studies) 60% 37% 3%
Comparative effectiveness (direct comparison of existing healthcare interventions) 64% 22% 15%
Basic science - human/translational studies 39% 47% 14%
Epidemiology (ex. large database studies) 28% 50% 22%
Gene discovery 40% 44% 18%
Outcomes 33% 47% 21%
Observational studies (ex. case studies, chart reviews) 23% 55% 25%
Basic science- animal/non-human studies 6% 46% 49%